Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)
NCT02045186 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2017-05-04
Summary
The purpose of this research study is to determine whether and when patients with human papilloma virus positive squamous cell cancer of the oropharynx treated with radiation and chemotherapy clear their human papilloma virus infection.
Conditions
- Carcinoma, Squamous Cell
- Head and Neck Neoplasms
- Oropharyngeal Neoplasms
Interventions
- OTHER
-
Assessment of Oral HPV Infection
Saliva and exfoliated oral epithelial cells will be collected with collection supplies provided by OralDNA Labs. Patients will swish and gargle a saline solution for 30 seconds and expectorate it into a funneled collection tube. The collected specimen will be sent to OralDNA Labs. Three diagnostic tests will be performed on each sample to assess oral HPV infection: 1. Polymerase chain reaction (PCR) for HPV DNA. 2. Fluorescent in-situ hybridization (FISH). 3. Viral expression: The test is based on the measurement of the viral RNA levels by methods of detection of the fluorochrome labeled HPV probes by flow cytometry.
Sponsors & Collaborators
-
UNC Lineberger Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Bhishamjit Chera, MD · University of North Carolina, Chapel Hill
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-11-30
Countries
- United States
Study Locations
More Related Trials
-
Men and Women Offering Understanding of Throat HPV
NCT03644563 ·Status: ACTIVE_NOT_RECRUITING
-
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
NCT06592716 ·Status: ACTIVE_NOT_RECRUITING
-
New Modalities for Detection of Oropharyngeal Cancer
NCT03226613 ·Status: COMPLETED ·Phase: NA
-
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
NCT04965792 ·Status: ACTIVE_NOT_RECRUITING
-
HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer
NCT01984359 ·Status: COMPLETED ·Phase: NA
-
Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
NCT06362421 ·Status: WITHDRAWN
-
Oropharynx (OPX) Salivary Biomarker Study
NCT05093400 ·Status: COMPLETED
-
Acceptability of Self-sampling for Cervical Cancer Screening
NCT05314907 ·Status: UNKNOWN ·Phase: NA
-
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
NCT05774561 ·Status: RECRUITING
-
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
NCT07087145 ·Status: RECRUITING
-
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study
NCT06115772 ·Status: RECRUITING
-
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
NCT00435214 ·Status: COMPLETED
-
CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas
NCT02981862 ·Status: COMPLETED ·Phase: NA
-
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
NCT04564989 ·Status: RECRUITING
-
Blood Biomarkers Based Screening for HPV-driven OPC
NCT06528353 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
HPV Self-sampling for Underscreened Latinas
NCT06439706 ·Status: COMPLETED ·Phase: NA
-
Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65
NCT05414929 ·Status: UNKNOWN ·Phase: NA
-
Detecting HPV DNA in Anal and Cervical Cancers
NCT04857528 ·Status: RECRUITING
-
Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia
NCT04274465 ·Status: COMPLETED
-
Clinical Evaluation of Detection of High Risk HPV in Urine
NCT05210348 ·Status: UNKNOWN
-
ctDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)
NCT06730412 ·Status: COMPLETED
-
Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers
NCT03604588 ·Status: UNKNOWN ·Phase: NA
-
Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
NCT04743674 ·Status: RECRUITING
-
New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer
NCT06097936 ·Status: UNKNOWN
-
Primary Cervical Cancer Screening by Self-sampling HPV Test
NCT05613283 ·Status: ACTIVE_NOT_RECRUITING